Explore the Latest Tacrolimus Tenders on Tender Impulse - Your Trusted Global Tender Website
Are you searching for the latest Tacrolimus Tenders from trusted sources across the globe? Tender Impulse is the go-to tender website for businesses seeking verified, timely updates on public tenders, government tenders and business tenders.
With real-time data and smart filters, you can find the most relevant Tacrolimus Tenders issued by ministries, public sector organisations and international procurement agencies - whether you're an SME or a multinational.
All-in-One Platform for Tacrolimus Tenders
- Requests for Proposals (RFPs) & Quotations (RFQs)
- General Procurement Notices (GPNs) & Expressions of Interest (EOIs)
- Prequalification documents, contract awards and amendments
Why Choose Tender Impulse?
- Custom email alerts tailored to your industry.
- Global coverage across 190+ countries and every major sector.
- Instant document access - specifications, BOQs and tender forms.
- Advanced filters by country, industry, deadline, value and procurement type.
Request a free live demo today and explore thousands of Tacrolimus Tenders and beyond.
1408400133690000-3 Various medicines Laboratory reagents NK 024 2023 code 61025 - Tacrolimus therapeutic medicinal IVD monitoring in vitro diagnostics kit immunochemiluminescent anaCountry: UkraineDeadline14 Aug 20267714452Germany Pharmaceutical products Open House Originale Rabattvertrge 2025-15 - Tacrolimus RetardtablettenCountry: GermanyDeadline31 May 20279064144Germany Pharmaceutical products Abschluss einer nicht-exklusiven Rabattvereinbarung nach 130a Abs 8 SGB V zum Wirkstoff Tacrolimus ATC D11AH01 fr die Zeit 01102025 - 30092027Country: GermanyDeadline05 Aug 20279181020Germany Pharmaceutical products Abschluss nicht exkl Arzneimittel-Rabattvereinb nach 130a Abs 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Tacrolimus ATC-Code nach WHOCountry: GermanyDeadline31 Oct 20269181580Germany Pharmaceutical products Abschluss nicht exkl Arzneimittel-Rabattvereinb nach 130a Abs 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Tacrolimus ATC-Code nach WHOCountry: GermanyDeadline31 Oct 20279206889Completion not excl pharmaceutical discount club according to section 130a 8 sgb v by means of an open house model to the active ingredient tacrolimus atc code according to whCountry: GermanyDeadline01 Nov 20279208043Completion not excl pharmaceutical discount club according to section 130a 8 sgb v by means of an open house model to the active ingredient tacrolimus atc code according to whCountry: GermanyDeadline01 Nov 202610544292Germany Pharmaceutical products Open house Arzneimittelrabattvertrge zum Wirkstoff Tacrolimus ATC D11AH01Country: GermanyDeadline30 Nov 202710567973Open house drug discount agreements for the active ingredient tacrolimus, ATC D11AH01Country: GermanyDeadline30 Nov 202711660346Germany Pharmaceutical products Arzneimittel mit dem Wirkstoff Tacrolimus ATC L04AD02Country: GermanyDeadline31 Mar 202812893813Germany Pharmaceutical products Open house Arzneimittelrabattvertrge Tacrolimus ATC D11AH01Country: GermanyDeadline03 May 202813149196Medicines - Conclusion of a non-exclusive discount agreement in accordance with Section 130a Paragraph 8 SGB V for the active ingredient tacrolimusCountry: GermanyDeadline05 Aug 202713149205Medicines - Conclusion not excluding medicine discount agreement. according to Section 130a Paragraph 8 SGB V through an open house model for the active ingredient tacrolimusCountry: GermanyDeadline31 Oct 202613149206Medicines - Conclusion not excluding medicine discount agreement. according to Section 130a Paragraph 8 SGB V through an open house model for the active ingredient tacrolimusCountry: GermanyDeadline31 Oct 202713278824Medicines - Conclusion of a non-exclusive discount agreement in accordance with Section 130a Paragraph 8 SGB V for the active ingredient tacrolimusCountry: GermanyDeadline05 Aug 202713338910Abschluss eines nicht exklusiven Rabattvertrages nach § 130a Abs. 8 SGB V zu Arzneimitteln mit dem Wirkstoff Tacrolimus (ATC-Code: L04AD02).Country: GermanyDeadline26 May 202813352750Open house Arzneimittelrabattverträge Tacrolimus, ATC L04AD02Country: GermanyDeadline02 Jun 202813387532Medicines - Conclusion not excluding medicine discount agreement. according to Section 130a Paragraph 8 SGB V through an open house model for the active ingredient tacrolimusCountry: GermanyDeadline31 Oct 202713390185Medicines - Conclusion of a non-exclusive discount agreement in accordance with Section 130a Paragraph 8 SGB V for the active ingredient tacrolimusCountry: GermanyDeadline05 Aug 202713390190Medicines - Conclusion not excluding medicine discount agreement. according to Section 130a Paragraph 8 SGB V through an open house model for the active ingredient tacrolimusCountry: GermanyDeadline31 Oct 202613486263Medicines - Conclusion of a non-exclusive discount agreement in accordance with Section 130a Paragraph 8 SGB V for the active ingredient tacrolimusCountry: GermanyDeadline05 Aug 202713486271Medicines - Conclusion not excluding medicine discount agreement. according to Section 130a Paragraph 8 SGB V through an open house model for the active ingredient tacrolimusCountry: GermanyDeadline31 Oct 202613486272Medicines - Conclusion not excluding medicine discount agreement. according to Section 130a Paragraph 8 SGB V through an open house model for the active ingredient tacrolimusCountry: GermanyDeadline31 Oct 202713562917Medicines - Conclusion of a non-exclusive discount agreement in accordance with Section 130a Paragraph 8 SGB V for the active ingredient tacrolimusCountry: GermanyDeadline05 Aug 202713562919Medicines - Conclusion not excluding medicine discount agreement. according to Section 130a Paragraph 8 SGB V through an open house model for the active ingredient tacrolimusCountry: GermanyDeadline31 Oct 2026
